NEW YORK and LOS ANGELES, July 1 (Reuters) - Allergan Inc may take on debt to buy back its own shares as part of a multi-faceted plan to thwart a $53 billion takeover bid by Valeant Pharmaceuticals...

from Reuters: Financial Services and Real Estate http://ift.tt/1kaU6DG
 
Tidak ada komentar:
Posting Komentar